Metraipolis › archive › dc_12f968f41765

SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications — Europe PMC PMID:42814168

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42814168
DOI
10.1186/s43556-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-10-07T18:08:02.838Z
SHA-256 of the archived text
9b8ed46a798a4cb5914eb2b1bd00490a10c664f45cfd5e6cef33e91abb108675
Stable URL of this page
https://metraipolis.com/documento/dc_12f968f41765

How to cite

SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications — Europe PMC PMID:42814168 — Europe PMC (en), https://europepmc.org/article/MED/42814168 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_12f968f41765 (Metraipolis archive dc_12f968f41765, sha256 9b8ed46a798a4cb5914eb2b1bd00490a10c664f45cfd5e6cef33e91abb108675)
BibTeX
@misc{dc12f968f41765,
  title = {SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications — Europe PMC PMID:42814168},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42814168},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_12f968f41765; sha256 9b8ed46a798a4cb5914eb2b1bd00490a10c664f45cfd5e6cef33e91abb108675},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42814168. Agents can read the archived copy with the MCP tool read_document.